Showing posts with label Chronic Pain. Show all posts
Showing posts with label Chronic Pain. Show all posts

Tuesday, September 5, 2017

Big Pharma Bias: FDA Grants ‘Breakthrough’ Status to Ecstasy for PTSD While Prohibiting Pot

cannabis

If there’s one refrain we hear from politicians more than anything else, it’s “I support the troops.” However, their definition of “support” changes with the political wind, and more often than not is a farce.


One example is the ongoing denial of medical cannabis to war veterans suffering from a range of conditions, from chronic pain to post-traumatic stress disorder (PTSD). Despite plenty of evidence—both scientific and real-world—that cannabis effectively treats these conditions, those who purportedly fought for freedom come home only to lose freedom under the War on Drugs.


The Veterans Administration (VA) still prohibits doctors from recommending cannabis or its extracts—including cannabidiol (CBD) which does not produce a high—even though most U.S. states acknowledge the science and have legalized medical cannabis.


The VA, perhaps emboldened by the Trump administration which is populated by 20th century prohibitionists, is digging in its heels. It funded two dubious studies questioning the effectiveness of medical cannabis—one finding “insufficient evidence to draw conclusions about benefits” for PTSD, and another concluding “limited evidence suggests that cannabis may alleviate neuropathic pain in some patients.”


Advertisment



This contrasts with a much larger review of literature carried out by the National Academies of Science, which concluded “patients who were treated with cannabis or cannabinoids were more likely to experience a significant reduction in pain symptoms.”


The VA doesn’t appear to care what the nation’s leading science body has to say, and it has no interest in finding out if cannabis works for PTSD. A major study on medical cannabis and PTSD in veterans being carried out by Dr. Sue Sisley is in danger of shutdown due to lack of participation by the VA.



READ MORE:  Woman, Arrested for Small Amount of Pot, Dies in Jail After Being Denied Prescriptions by Cops



It seems that every time there is hope for veterans to gain legal access to medical cannabis, those hopes are dashed by a minority of lawmakers. The latest letdown was the Veterans Equal Access amendment, which would have allowed access in states with medical cannabis laws, but the amendment was stripped out in committee.



Facing this betrayal by lawmakers and the VA, veterans must become criminals if they want to try medical cannabis where prescription drugs have failed.


While federal government keeps cannabis as a Schedule 1 drug with “no medical use,” the same government has just granted “breakthrough therapy designation” to another drug in the Schedule 1 category—MDMA or ecstasy.



The ‘party drug’ was used in Phase 2 trials on roughly 200-300 patients with severe PTSD. Results showed a remarkable improvement in most patients, with 61 percent reporting no PTSD symptoms after 2 months and 68 percent being PTSD-free after a year.


With the “breakthrough” status granted by FDA, Phase 3 trials can proceed much more quickly, and with input on “design, primary endpoint, and statistical approach” from FDA. Pharmaceutical companies will surely be looking to cash in on this development with patented versions of ecstasy.


“For the first time ever, psychedelic-assisted psychotherapy will be evaluated in Phase 3 trials for possible prescription use, with MDMA-assisted psychotherapy for PTSD leading the way,” said Rick Doblin, Executive Director of the Multidisciplinary Association of Psychedelic Studies.


Government appears completely willing to set aside the drug war for manufactured compounds in their “controlled substances” roster, but when it comes to medicine that people can grow themselves, no such freedom is allowed.



READ MORE:  2 Young Adults and a Toddler Killed in Crash After Police Initiate 100mph Chase Over Drugs



Cannabis and psilocybin both show promise for treating PTSD, perhaps even more so than MDMA. Psilocybin has demonstrated incredible ability to heal mental illness in clinical trials, but it hasn’t received any “breakthrough status,” just as medical cannabis remains mired in federal prohibition.



These natural substances cannot be monopolized by Big Pharma like manufactured chemical drugs, so they get no help from federal government. Meanwhile, veterans continue paying the price.

Tuesday, August 1, 2017

For the First Time, NFL Acknowledges Benefits of Cannabis, Offers to Study it for Pain

NFL

The NFL is finally acknowledging that cannabis has the potential to treat acute and chronic pain. A report out today says that the NFL has sent a letter to the Player’s Association (NFLPA) indicating it is willing to study the use of medical cannabis for pain management.


The NFLPA, apparently quicker to grasp the conclusions of science, is already studying the issue. In Jan. 2017, the National Academies of Science (NAS) released an exhaustive study on the therapeutic benefits of cannabis, with chronic pain treatment being one of the most significant.


Players in America’s favorite sport are plagued by pain, often for the rest of their lives, and many have already turned to medical cannabis whether the league allows it or not. Soon after the NAS study, retired football players were telling their stories of lives virtually ruined by pain and the standard drugs given to them such as opioid pills – only to find relief with cannabis.


Advertisment



Now, former NFL players are trying to open medical cannabis dispensaries and extolling the benefits of this medicinal plant. They are on the right side of history, and the NFL may finally be catching up.


Cannabis use remains banned by the league, with players regularly tested and penalized if THC is detected. At the moment, the NFL is still stuck in the Reefer Madness mentality, thinking that because federal government prohibits the plant, then they should as well. But the letter to the NFLPA is an encouraging sign.




“We look forward to working with the Players Association on all issues involving the health and safety of our players,” said Joe Lockhart, the NFL’s executive vice president of communications…


The NFL, according to one person with knowledge of the matter, wrote a letter to the union asking if, given the NFLPA’s public comments on the issue this year, it is interested in working together on research. The league’s letter outlined a few areas for potential research that included pain management for both acute and chronic conditions.”



The NFLPA is also seeking to reduce punitive measures for the use of cannabis, which is especially needed now that recreational cannabis is legal in eight states and 26 other states have legalized medical use only.



READ MORE:  As Feds Claim Pot Has "No Medicinal Use" FDA Approving Horse Tranquilizer for Depression



“I do think that issues of addressing it more in a treatment and less punitive measure is appropriate,” said DeMaurice Smith, NFLPA’s executive director. “I think it’s important to look at whether there are addiction issues. And I think it’s important to not simply assume recreation is the reason it’s being used.”


The issue of opioid abuse is another reason why the NFL should adopt a more reasonable approach to medical cannabis. Opiates are routinely handed out to players for acute and chronic pain, making them prone to join the ever-growing ranks of those addicted to these dangerous legal drugs. We know from multiple studies that people are giving up deadly, addictive opioids in favor of cannabis in states where it is legal.



In addition to a safer method of pain management, medical cannabis can help prevent brain damage, which is also pervasive in NFL players. A recent major study found that “a vast majority of the brains of deceased players that were studied showed signs of chronic traumatic encephalopathy, a degenerative condition linked to head trauma.”


In response to this, Doctors for Cannabis Regulation is lobbying the NFL to change its irrational rules on cannabis. It should be noted that medical cannabis can be administered with no psychoactive effects.


“There is some early data that cannabis does play a role in neuroprotection. This is the kind of science we’ve put in front of the NFL, hoping they would reconsider their antiquated policies,” Dr. Suzanne Sisley told The Chronicle. “The bottom line is that cannabinoids are clearly neuroprotective. We have preclinical data at the receptor level that cannabinoids and cannabis are not only involved with brain repair but neurogenesis, the development of new neural tissue. It’s one of the most exciting discoveries of modern neuroscience.”




READ MORE:  "War on Cops" Debunked: Police Killings Lower Since Last Year, in Steady Decline for 3 Decades



The NFL appears to have taken the first step in embracing factual evidence and science. Hopefully this will continue, as other entities such as Big Pharma and the alcohol industry will surely lobby against relaxing the NFL’s current prohibitionist stance.

Tuesday, May 30, 2017

New Study Reveals Why Cannabis is Still Illegal, Legal Pot DESTROYS Big Pharma Profits

cannabis



The question of why cannabis remains illegal becomes more unavoidable by the day, as scientific evidence mounts for its medicinal powers and states continue to decriminalize the plant. The legal drugs of alcohol and nicotine kill hundreds of thousands every year and have little to no medical value – but the ingestion of cannabis kills no one, and heals many.


The war on drugs itself is an utter failure by the metrics it was supposed to address – drug availability, drug prices and drug use. With the absence of any rational basis for prohibition, it begs the question of what actually sustains it.


We know the State profits immensely from the drug war, acquiring wealth and power by arbitrarily naming certain substances “illicit.” In the modern-day corporatocracy, certain industries profit as well, most notably prisons and various entities involved in State oppression.


In the area of cannabis, perhaps the biggest beneficiary to prohibition is the pharmaceutical industry. Big Pharma tried and mostly failed to defeat the groundswell movement of cannabis legalization in many states. But it seems to have a friend in the federal Drug Enforcement Administration (DEA), which against all reason decided to keep cannabis a Schedule 1 Controlled Substance.



Big Pharma admitted that legal cannabis poses a threat to its profit, and that reality is underscored in a new analysis from New Frontier Data. If medical cannabis were adopted in all 50 states, it would siphon about $4.5 billion a year from the pharma industry.



“New Frontier Data identified nine conditions in particular to assess the impact of the legalization of cannabis would have on prescription drug use.


Among those, spending on treatments for chronic pain and post-traumatic stress disorder (PTSD) represented about 60% of the total. Overall in 2016, it was estimated that patients spent nearly $14.3 billion and $10.6 billion, respectively, to treat chronic pain and PTSD. The costs to treat sleep disorders, anxiety, epilepsy, nerve pain, chemotherapy-induced nausea and vomiting (CINV), Tourette syndrome, and glaucoma collectively accounted for the other 40% dedicated toward treatments.


There is significant savings to be realized in the health care system both to consumers and the U.S. government. It is estimated that cannabis and related products can replace between $4.4 billion and $4.9 billion of current annual spending on those existing treatments.”



In a press release, New Frontier CEO Aguirre De Carcer said, “Looking at these numbers, it would appear that medical cannabis would be a drop in the bucket when it comes to impacting the total pharmaceutical industry. However, when you start to break down the numbers by specific sectors of the industry, like chronic pain or symptoms associated with chemotherapy, which are very lucrative markets for pharmaceutical companies, you will certainly see cannabis have a major impact.”




READ MORE:  Sick NYPD Cop Charged With Conspiring To Molest 1 Year Old Child



They referenced a July 2016 study which found that, on average, about 11 percent of patients in legal weed states are successfully replacing prescription drugs with medical cannabis. This, along with other studies, prompted New Frontier Data to look further into the dynamic of medical cannabis and pharmaceutical drugs.


A National Academies of Science study identified nine specific conditions where medical cannabis can have a beneficial role – including chronic pain and post-traumatic stress disorder (PTSD) – which were used by New Frontier Data for their analysis. Another report showed that taxpayers could save $1.1 billion on Medicaid prescriptions annually if medical cannabis were legalized nationwide.


“Any opportunity for alternatives that could result in reduced pharmaceutical drug use might present a compelling point of discussion from a public policy standpoint,” said John Kagia, executive vice president of industry analytics at New Frontier.


The problem is, public policy is largely controlled by interests that have no desire to reduce profits by reducing prescription drug consumption, and have no desire to relinquish power by decriminalizing a medicinal plant that harms no one.


Judging by DEA chief Chuck Rosenberg, his agency will continue taking the lead in government’s war on people. Only a few days ago Rosenberg reminded us of the staggering, willful ignorance that guides the drug war, stating, “Marijuana is not medicine.”